telmisartan has been researched along with Uveitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, H; Ishida, S; Kezuka, T; Nagai, N; Okunuki, Y; Takeuchi, M; Usui, Y | 1 |
| Inoue, M; Ishida, S; Koto, T; Kubota, Y; Nagai, N; Noda, K; Oike, Y; Ozawa, Y; Shinoda, H; Shinoda, K; Suda, T; Tsubota, K; Urano, T; Yamashiro, K | 1 |
| Inoue, M; Ishida, S; Kurihara, T; Nagai, N; Oike, Y; Okano, H; Ozawa, Y; Shinoda, K; Tsubota, K | 1 |
3 other study(ies) available for telmisartan and Uveitis
| Article | Year |
|---|---|
Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Benzimidazoles; Benzoates; Cell Adhesion; Chemokine CCL2; Cytokines; Disease Models, Animal; Down-Regulation; Eye Proteins; Female; Flow Cytometry; Hypersensitivity, Delayed; Intercellular Adhesion Molecule-1; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Retinitis; Retinol-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Telmisartan; Uveitis | 2009 |
Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aqueous Humor; Benzimidazoles; Benzoates; Blotting, Western; Cell Adhesion; Disease Models, Animal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Eye Proteins; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Leukocytes; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Receptor, Angiotensin, Type 1; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Up-Regulation; Uveitis | 2005 |
Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Dark Adaptation; Disease Models, Animal; Electroretinography; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Immunoblotting; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Neuroglia; Neuroprotective Agents; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Retina; Rhodopsin; STAT3 Transcription Factor; Synaptophysin; Telmisartan; Uveitis | 2006 |